Potential Impact of cfDNA Technologies in Disease Management

Apr 22, 2019 | Ethan McConkey, Moderator | @ethanmcconkey

2019-05-07 DA

Cell free DNA (cfDNA) are degraded DNA fragments released to the blood stream during health and disease. This discovery was made more than 50 years ago. However, it was not until recently with the advent, scalability and affordability of next generation sequencing that cfDNA has become an approach to study biomarkers for disease progression. In our recent review on cfDNA, published in the "Therapeutic Advances in Gastroenterology", we discuss the principals, current advances and future applications about cfDNA technologies including their use in gastrointestinal and liver disease

The PDF of the published article can be found here.

Join others discussing PSC

Interested in more newsfeed posts like this? Go to the Primary Sclerosing Cholangitis (PSC) blog.

Please sign in or register to post a reply.
  Request Appointment